The Venture Codex Logo

The Venture Codex

Overview

Non-profit clinical research center specializing in cancer treatment.

Founded

1913

Deals ยท 12mo

0

Stage focus

Series A
Series B

Geographic focus

United States

Sector focus

Association
Education
Health Care

Investment portfolio

2rounds
NAMEDATESIZE
AccessHope
Apr 2024Led
$33 MSeries B
Reimagine Care
Jan 2022Participated
$25 MSeries A
AccessHope
Apr 2024Led
$33 MSeries B
Reimagine Care
Jan 2022Participated
$25 MSeries A
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

City of Hope: 2 funding rounds are recorded in the selected participation categories.All available history.
City of Hope: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B10

Monthly Deal Activity

City of Hope: 2 deals are recorded across 58 months.All available history.
City of Hope: 2 deals are recorded across 58 months. All available history
MonthDeals
Jan '221
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

City of Hope: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

City of Hope: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2

Deal Size Distribution

City of Hope: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

City of Hope: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M2
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

City of Hope: United States has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

City of Hope: United States has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
United States2
City of Hope: 6 co-investors are shown, with CU Healthcare Innovation Fund sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

City of Hope: 6 co-investors are shown, with CU Healthcare Innovation Fund sharing 1 recorded deals. All available history
Co-investorShared deals
CU Healthcare Innovation Fund1
LRVHealth1
Martin Ventures1
McKesson Ventures1
Sable Investments1
Sante Ventures1

Investment Strategy

City of Hope: Led accounts for 50% and participating for 50% of round participation.All available history.
City of Hope: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led150%
Participating150%
City of Hope: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
City of Hope: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Alan H. Bryce

Chief Clinical Officer

Craig Todd

lead ir

Harlan Levine

President, Strategy and Business Ventures

Jessica Velasquez

Registered Nurse

Milad Riazifar

Scientist - Department of Cellular Therapeutics

Patricia Thompson

Medical Oncologist

Samuel Lau

Vice President of Marketing

Terry Peets

Chairman Emeritus and Director